Holen Sie sich die Stockscreener-App
2.40
0.84%
0.02
Handel nachbörslich:
2.40
Schlusskurs vom Vortag:
$2.38
Offen:
$2.38
24-Stunden-Volumen:
41,063
Relative Volume:
0.47
Marktkapitalisierung:
$98.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.92M
KGV:
-8.00
EPS:
-0.3
Netto-Cashflow:
$-7.05M
1W Leistung:
-11.11%
1M Leistung:
+44.58%
6M Leistung:
+80.45%
1J Leistung:
+29.73%
1-Tages-Spanne:
$2.34
$2.45
1-Wochen-Bereich:
$2.22
$2.6865
52-Wochen-Spanne:
$0.8001
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Firmenname
Anebulo Pharmaceuticals Inc
Sektor
Branche
Telefon
737 203 5270
Adresse
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Vergleichen Sie ANEB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.40 | 97.37M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Anebulo Pharmaceuticals Inc Aktie (ANEB) Neueste Nachrichten
Long term hold vs stop loss in Anebulo Pharmaceuticals Inc.July 2025 News Drivers & High Accuracy Investment Signals - Newser
Chart based exit strategy for Anebulo Pharmaceuticals Inc.2025 EndofYear Setup & Precise Swing Trade Alerts - Newser
Comparing Anebulo Pharmaceuticals Inc. in custom built stock radarsJuly 2025 News Drivers & Consistent Growth Stock Picks - Newser
Real time pattern detection on Anebulo Pharmaceuticals Inc. stockJuly 2025 PreEarnings & AI Enhanced Trading Alerts - Newser
Should you wait for a breakout in Anebulo Pharmaceuticals Inc.2025 Year in Review & Momentum Based Trading Ideas - Newser
Reviewing Orchestra BioMed (NASDAQ:OBIO) & Anebulo Pharmaceuticals (NASDAQ:ANEB) - Defense World
How to forecast Anebulo Pharmaceuticals Inc. trends using time seriesTechnical Trend Forecast for Investors - Newser
Volume spikes in Anebulo Pharmaceuticals Inc. stock – what they meanHigh Return Idea With Technical Filter - Newser
Is Anebulo Pharmaceuticals Inc. part of any ETFHigh Velocity Stock Movers - thegnnews.com
How to integrate Anebulo Pharmaceuticals Inc. into portfolio analysis toolsFree Real Trader Watchlist of Hot Stocks - Newser
Using AI based signals to follow Anebulo Pharmaceuticals Inc.Free Triple Digit Growth Focused Trade Plan - Newser
Is Anebulo Pharmaceuticals Inc. stock poised for growthFree Risk Controlled Short Term Trade Plans - Newser
News impact scoring models applied to Anebulo Pharmaceuticals Inc.Sector-Wise Equity Performance Trend Forecast - Newser
Using fundamentals and technicals on Anebulo Pharmaceuticals Inc.Predictive Model for Intraday Swing Forecast - Newser
What makes Anebulo Pharmaceuticals Inc. stock price move sharplyAI-Based Stock Behavior Forecast Engine - Newser
How institutional ownership impacts Anebulo Pharmaceuticals Inc. stockSecure Asset Flow and Trend Pattern Analysis - Newser
Is Anebulo Pharmaceuticals Inc. meeting your algorithmic filter criteriaFree Conservative Long Term Growth Plans - Newser
Anebulo Pharmaceuticals Inc. Earnings Report Breakdown: What Investors Should KnowFree Daily Growth Stock Pick Reports - Newser
Technical Models Detect Momentum Build in Anebulo Pharmaceuticals Inc.Pattern Alert With ROI Driven Strategy Shared - beatles.ru
Will Anebulo Pharmaceuticals Inc. stock recover after recent dropFree Target Return Focused Trade Insights - Newser
What are Anebulo Pharmaceuticals Inc. company’s key revenue driversMarket-crushing profits - Jammu Links News
Finanzdaten der Anebulo Pharmaceuticals Inc-Aktie (ANEB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):